Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasma Endocannabinoid Levels in Patients with Borderline Personality Disorder and Healthy Controls.

International journal of molecular sciences - 14 Dec 2023

Spohrs Jennifer, Kühnle Valentin, Mikusky David, Sanhüter Niklas, Macchia Ana, Nickel Sandra, Abler Birgit

Abstract excerpt

Borderline personality disorder (BPD) is a highly prevalent psychiatric disorder and presents a complex therapeutic challenge due to limited treatment modalities. Recent focus has converged on the endocannabinoid system (ECS) as a prospective modulator of psychopathological processes in BPD. To address this hypothesis, we analysed plasma endocannabinoid concentrations, specifically anandamide (AEA) and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amidohydrolases
Share to Borderline Personality Disorder

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endocannabinoids

Share to Genotype

Share to Homozygote

Source

Open in PubMed Open full text

Identifiers

PMID: 38139281
DOI: 10.3390/ijms242417452
PMCID: PMC10743563

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasma Endocannabinoid Levels in Patients with Borderline Personality Disorder and Healthy Controls.PMID 38139281Read ↗

Phenotype, endophenotype, and genotype comparisons between borderline personality disorder and major depressive disorder.Semantic proximity Read ↗

Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidenceSemantic proximity Read ↗

Sex Differences in Endocannabinoid and Inflammatory Markers Associated with Posttraumatic Stress DisorderSemantic proximity Read ↗

[Neurobiology in borderline personality disorder].Semantic proximity Read ↗

[Genetic association analyses of the endocannabinoid system on anxious phenotype].Semantic proximity Read ↗

Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function.Semantic proximity Read ↗

Genetic variation in endocannabinoid signaling: Anxiety, depression, and threat- and reward-related brain functioning during the transition into adolescence.Semantic proximity Read ↗

Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor.Semantic proximity Read ↗

Association of cannabinoid receptor genes (CNR1 and CNR2) polymorphisms and panic disorder.Semantic proximity Read ↗

Comparison of endocannabinoids levels, FAAH gene polymorphisms, and appetite regulatory substances in women with and without binge eating disorder: a cross- sectional study.Semantic proximity Read ↗

The Endocannabinoid System and Anxiety.Semantic proximity Read ↗

FAAH Gene Variation Moderates Stress Response and Symptom Severity in Patients with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.